Literature DB >> 15209922

Exploiting alloreactivity for tumour immunotherapy.

H J Stauss1, S Xue, R Gillmore, L Gao, G Bendle, A Holler, A-M Downs, E Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15209922     DOI： 10.1111/j.1741-6892.2004.00493.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  2 in total

Review 1.  Engineering T cells for cancer therapy.

Authors:  W Mansoor; D E Gilham; F C Thistlethwaite; R E Hawkins
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

2.  Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response.

Authors:  Alejandro Pando; Loren Fast; Patrycja M Dubielecka; Anna Chorzalska; Sicheng Wen; John Reagan
Journal:  J Blood Med       Date:  2021-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.